In this issue:
- Ceftriaxone as definitive therapy for MSSA bacteraemia
- Empirical vs. pre-emptive antifungals in high-risk neutropenic patients on fluconazole prophylaxis
- Antibiotic treatment duration in P. aeruginosa ventilatorassociated pneumonia
- Syphilis RPR titre changes between diagnosis and treatment
- Piperacillin-tazobactam vs. cefepime/carbapenem for immunocompromised, cefoxitin-nonsusceptible bacteraemia
- Highly vs. less bioavailable oral antibiotics for gram-negative BSIs
- Hospital-acquired BSIs in ICUs
- Postexposure doxycycline to prevent bacterial STIs
- Treatment strategies for rifampicin-susceptible TB
- Azithromycin to prevent sepsis or death in women planning vaginal delivery
Please login below to download this issue (PDF)